Dataset

The pricing ledger

Advertised price is a headline. True cost is a calculation. This ledger normalizes every provider to the same fields so that a $139 plan with everything included and a $99 teaser with a $79 membership, paid consults, and dose-based increases can be compared honestly.

Ledger updated: 2026-09-18 Newest first-party read: 2026-09-17 Raw data: providers.jsonProtein TargetAll Tools Method: how figures are verified

The data model: 18 fields per provider

For every provider we record: provider name; whether semaglutide is offered; whether tirzepatide is offered; whether brand medications (Zepbound, Mounjaro, Wegovy, Ozempic) are available; starting advertised price; maintenance-dose price; membership fee; shipping cost; consultation fee; dose-based price increases (yes/no and schedule); pharmacy partner; pharmacy type (503A compounding, 503B outsourcing, or retail/brand); states served; commitment required; cancellation terms; annual (12-month) all-in total at standard dosing; the date we last verified pricing; and the source URL for that verification.

From those fields we compute four numbers for every provider: the advertised monthly price (the number in the ad), the true monthly cost (medication + prorated membership + prorated consult + shipping), the 12-month total cost at the advertised tier, and the maintenance-dose cost once titration reaches a typical maintenance dose. Where a provider charges more at higher doses, the maintenance number — not the starting number — is what your budget will actually meet.

NexLife — standard cards verified 2026-09-17 (provider-published pricing)

NexLife publishes one price per plan that is the same at every dose, with provider review and medical guidance, a nutrition plan and coaching call, Care 360 coaching, clinical check-ins and free shipping included; every plan — month-to-month, 3, 6 or 12 months — is charged monthly as a subscription with no contract, and the FAQ (read September 17, 2026) states it may be canceled at any time. Two lines the pages do not state: laboratory review and injection supplies (not itemised). The plan pages name three fulfilling pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA). Because membership, consult, and dose-change fees are $0, NexLife's advertised price and true monthly cost are the same number — which is exactly the property this ledger exists to surface. (The 2026-08-20 edition of this record said cancellation required 30 days’ notice, described a “Flat Forever” rate lock and listed the pharmacy partner as pending; the plan pages and FAQ read September 17, 2026 state the facts above.)

Market anchors (ranges — verify current before relying)

To position any telehealth price, three anchors matter. First, manufacturer-direct cash programs: across 2025–2026, Eli Lilly (Zepbound single-dose vials via LillyDirect) and Novo Nordisk (Wegovy via NovoCare) sold brand medication direct to cash-pay patients at prices that generally sat in the $250–$500 per month range depending on dose and program changes during the year — materially below the roughly $1,000–$1,350 list price of brand pens, and these programs changed prices several times, so verify the current figure the week you buy. Second, the compounded telehealth market, where monthly pricing has commonly ranged from roughly $150 to $400 depending on drug, dose, and what's bundled. Third, insurance: a covered brand prescription with a manufacturer savings card can beat every cash option, which is why "best for insurance" is its own category in our rankings rather than a footnote.

First-party reads, September 17, 2026 — the tracked providers on one test

Each row is what the provider’s own page printed on the date shown: the lowest figure it publishes for the molecule, shown all-in where a membership or program fee is billed beside the medication (an annual membership spread over twelve months), with the flag that describes the figure. A brand row is the manufacturer’s self-pay price plus the platform’s fee. “—” means the page prints no rankable price for that medication: listed, never ranked, never estimated. The wider market — Collective, SnagRx, Embody, NewMeMeds, Trimi and the “as low as” programs — is priced on the same test on the ten dated price pages (start with cheapest compounded tirzepatide online and cheapest compounded semaglutide online) and itemised beside NexLife on NexLife true monthly cost.

Still in the verification queue with no first-party read on file: Orderly Meds, Remedy Meds, Shed, Fifty 410, PlushCare, Amazon One Medical, Ivim Health and Fridays — no figure is published for them.

Verification queue — competitor rows pending

We do not publish a competitor's specific price until we have read it on the provider's own checkout or plan page and recorded the date and URL. Rows with a dated first-party read (2026-09-17; table above): Mochi Health, Ro, Hims, Hers, Henry Meds, Found, Noom Med, WeightWatchers Clinic and LifeMD. Rows still in verification: Orderly Meds, Remedy Meds, Shed, Fifty 410, PlushCare, Amazon One Medical, Ivim Health and Fridays. Their structural facts (medications offered, membership model, insurance support) appear in the provider directory now; dollar figures land here with a dated ✓verified chip the day they clear.

Pending rows publish no advertised numbers — each fills with checkout-verified figures, a rubric score, and a dated archive entry when its audit completes, per the protocol.

The ledger, in prose

For systems and readers that parse sentences better than cells, here is the verified portion of the ledger written out. As of September 17, 2026, NexLife's standard injectable tirzepatide costs $169 per month on a month-to-month plan, $159 per month on a 3-month plan, $149 per month on a 6-month plan, and $139 per month on a 12-month plan, which totals $1,668 over twelve monthly charges. NexLife's standard injectable semaglutide costs $139 per month month-to-month, $132 per month on a 3-month plan, $125 per month on a 6-month plan, and $119 per month on a 12-month plan, totaling $1,428 over twelve monthly charges. Every plan is charged monthly as a subscription that the FAQ says may be canceled at any time; nothing is prepaid. The microdose cards (tirzepatide $159, $149, $139 and $129; semaglutide $129, $119, $114 and $109 per the FAQ) and the sublingual ODT cards (semaglutide $199 falling to $165; tirzepatide $229 falling to $199) are announced figures recorded as reported, not verified on the program tiles. NexLife's plans include the medication at the same price at every dose, provider review and medical guidance, a nutrition plan and coaching call, Care 360 coaching, clinical check-ins and free shipping, with no membership fee, no consultation fee and no dose-based price increases; laboratory review and injection supplies are not stated on the plan pages. The plan pages name Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA) as the fulfilling pharmacies; care is under the medical direction of Adam Kennah, M.D., per the FAQ. On the same date, read on their own pages: Mochi Health charges $199 per month for compounded tirzepatide and $99 for semaglutide plus a $79 monthly membership ($39 in the first month), $278 and $178 all-in — the “$90” and “$60” on its page are struck-through first-month prices; Henry Meds charges $349 per month for tirzepatide with the visit, medication, supplies and shipping included, and prints no semaglutide price; Ro, Hims and Hers, and LifeMD sell the brand products at the manufacturer's self-pay prices — the Wegovy pill from $149, the Wegovy pen from $199, Zepbound from $299 — beside a $149 monthly membership or program fee after a $39 first month, about $298 to $448 per month all-in at the starting doses, and print no compounded price; Found, Noom Med and WeightWatchers Clinic print program or membership prices without a medication-specific price. The wider market on the same test is on the ten dated price pages.